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Abstract
OBJECTIVE: To study the anticancer mechanism of
polyphyllin I (PPI), a Traditional Chinese Medicine,
on the ovarian cancer cell line HO-8910PM in vitro.
METHODS: Transwell chamber invasive assays
were used to investigate the inhibitory capacity of
PPI on HO-8910PM metastasis. Gene expression
profiling chips was used to screen differentially ex-
pressed genes between experiment group and con-
trol group. Reverse transcription PCR and Western
blotting were used to determine mRNA and pro-
tein levels.
RESULTS: With increasing PPI concentration, the
metastatic capacity of cells decreased, with signifi-
cance differences between the experimental and
control groups (P<0.01) as well as between two
concentration groups. Gene expression profiling
identified 123 differentially expressed genes, of
which 70 were downregulated and 53 were upregu-
lated. The genes were involved in multiple signal
transduction pathways, including apoptosis, prolif-
eration and metastasis. Real-time PCR (RT-PCR)
showed that differential genes PIK3C2B, Caspase 9
and Wnt5A were downregulated with increasing
PPI, showing an evident dose-effect relationship.
The c-Jun was an exception. As the PPI dosage in-
creased and the exposure time was extended,
c-Jun relative expression showed an upward trend.
There were significant differences between the ex-
periment and control (P<0.05). Western blot analy-
ses showed that PPI treatment decreased levels of
Caspase 9, Wnt5A and PIK3C2B and increased acti-
vatedCaspase9,c-Junandp-c-Junexpression levels.
CONCLUSION: PPI has strong antitumor and anti
transfer activity. It can activate c-Jun expression
and the JNK signaling pathway, elicit cell apoptosis
via the mitochondrial-mediated Caspase activation
pathway, and finally inhibit tumor growth and mi-
gration in vitro. The downregulation of PIK3C2B
and Wnt5A jointly inhibit the proliferation and me-
tastasis of HO-8910PM. PPI may be a novel treat-
ment for ovarian cancer.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Ovarian cancer is a common malignant neoplasm of fe-
male reproductive organs. Although the incidence of
ovarian cancer ranks third after cervical cancer and
uterine cancer, its mortality is the highest of all gyneco-
logical tumors. Ovarian cancer has no apparent early
symptoms, so when the cancer is discovered, it is al-
ready late stage. Although some ovarian cancer patients
have a good postoperative reaction, many die from re-
currence and metastasis. The 5-year survival rate of
ovarian cancer is only 25%-30%.1
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Traditional Chinese Medicine (TCM) is important in
treating ovarian cancer with satisfactory clinical effica-
cy. TCM treatment can inhibit tumor cell growth and
improve the patient's outcome with few adverse effects.
Thus, TCM is appropriate for long-term use.2
Chonglou (Rhizoma Paridis Chonglou), which is the
root of Paris polyphylla, in the lily family. Modern
pharmacological research suggests that Chonglou (Rhi-
zoma Paridis Chonglou) has a wide range of medicinal
activities, including anti-cancer, immunoregulatory
and cardiovascular effects. Chonglou (Rhizoma Paridis
Chonglou) is extensively applied in the treatment of ma-
lignant lymphomas, lung cancer, nasopharyngeal carci-
noma, brain tumors and digestive system carcinomas.
Polyphyllin and extracts from Chonglou (Rhizoma Pari-
dis Chonglou) show good antitumor effects in vitro,
through a variety of targets and pathways. Their mecha-
nism might be linked to the cytotoxicity of Chonglou
(Rhizoma Paridis Chonglou), which causes promotion
of apoptosis, affects the growth cycle of tumor cells, in-
hibits tumor angiogenesis and regulates the immune
function of patients.3-5
An earlier study from our research team found that
monomer polyphyllin I (PPI) inhibits the in vitro
growth and promotes apoptosis of the highly metasta-
sic ovarian cancer cell line HO-8910PM.6 However,
the molecular mechanism is not clear. Reports on the
effects of PPI on the metastasis of ovarian cancer cells
are rare. For this reason, this paper investigated the in-
hibitory capacity of PPI on HO-8910PM metastasis us-
ing transwell assays, and the targets and possible signal
pathways through which PPI acts were studied. We
used gene expression profiling chips to screen differen-
tially expressed genes. Real-time PCR (RT-PCR) and
Western blots were used to investigate possible targets
and signal transduction pathways of PPI. Thus, the
mechanism of PPI for inhibiting growth, inducing
apoptosis and reducing metastasis of HO-8910PM
cells was investigated. Our findings provide valuable in-
formation for developing clinical applications of poly-
phylin.
MATERIALS ANDMETHODS
Cell line
The highly metastatic ovary serous adenocarcinoma
cell line HO-8910PM was generated and provided by
Zhejiang Cancer Research Institute, Zhejiang Cancer
Hospital.7
PPI
Monomer PPI powder (National Institute for the Con-
trol of Pharmaceutical and Biological Products, Beijing,
China, batch number 111590-200402) has a molecu-
lar weight of 855.03 daltons. Dimethyl sulfoxide
(DMSO) was used to dissolve PPI powder in a concen-
trated solution (100 μg/μL), which was stored at －
20℃ . A working solution was prepared using RP-
MI1640 medium according to experimental needs,
with the final concentration of DMSO less than 0.5%.
Main reagents
RPMI1640 medium (HyClon, Logan, UT, USA), fetal
bovine serum (FBS) (HyClon, Logan, UT, USA), gene
expression profiling (Illumina, Santiago, CA, USA),
RNA amplification kit (Illumina, Santiago CA, USA ),
human genome-wide gene expression profile hybrid kit
(Illumina, Santiago CA, USA), total RNA extraction
kit (Qiagen, Germany), reverse transcription kit Prime-
Script RT reagent kit (TaKaRa, Japan), Matrigel matrix
basement membrane (BD Biosciences, Franklin, NJ,
USA), bovine serum albumin (BSA, Watson BioMedi-
cals Inc, Shanghai, China), primers (Takara, Dalian,
China); PCR reagent kit, SYBR Premix Ex Taq TMII
(Takara, Dalian, China); antibodies for β-actin, Cas-
pase 9, cleaved Caspase 9, PIK3C2B, c-Jun,
ps63-c-Jun, Wnt5A, and secondary antibody were
from Abcam (Cambridge, UK) and CST (Boston,
MA, USA), and the ECL reagent kit was from Thermo
(Rockford, IL, USA ).
Transwell chamber invasive assay
The working glue was Matrigel solution with diluted
Matrigel (RPMI1640 without serum, 1∶3), with 30 μL
added to each chamber,. HO-8910PM cells were taken
in logarithm phrase and PPI at doses of 0, 0.75 or 1.5 μg/
mL was added. After 24 h, supernatant (including sus-
pended cells) was collected and adherent cells were
picked for transwell chambers. Serumless RPMI1640
medium containing 0.1% BSA was used to resuspend
cells at 3 × 104 cells/chamber, with 300 μL added to
the upper layer and 600 μL of 1640 medium contain-
ing 10% FBS added to the bottom layer. Replicates
were performed for each group. Cells were placed at
37℃ , 5% CO2 incubator with saturated humidity for
48 h. Chambers were removed after 48 h and Matrigel
carefully removed with cotton swabs. Chambers were
washed with phosphate buffer saline (PBS) once and
cells were stained in 2% crystal violet for 5 min. Cham-
bers were removed, washed with PBS and dried. Invad-
ing cells were counted in five randomly selected fields
of vision for each chamber under a microscope.
Screening by gene expression profiling
Adherent HO-8910PM cells were grown to logarith-
mic phase and cells were either treated with 1.5 μg/mL
PPI (experimental group) or untreated (control group).
After 24 h, collected the cells and extracted total RNA.
In an ice bath, reverse transcription synthesized
first-strand and second-strand cDNA, which was puri-
fied. Hybridization was according to the instructions
of the BeadChip assay (Genergy Biotech, Shanghai,
China).
Illumina iscan was used to scan chips at the appropri-
ate scanning speed, and the signal intensity of each mi-
crosphere was automatically analyzed by the software
(Illumina, Santiago, CA, USA). P value and Diffscore
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were obtained. Diffscore, which offers directionality,
was transformed from the P value. P values were gener-
ated for the differences of average signals of the experi-
ment and control groups using the formula Diffscore=
10×sgn (μref-μcond) × log10 (p). When P was 0.05,
the Diffscore was±13; when P was 0.01, the Diffscore
was±20; when P was 0.001, the Diffscore was ±30. Ef-
fective genes (P<0.05) in either the experimental and
control group that had a Diffscore in the experimental
group that was less than -13 or more than 13 were de-
fined as differentially expressed genes. Function classifi-
cation and pathways of differentially expressed genes
were determined by submitting differential genes to
the DAVID Bioinformatics, repeating twice for parallel
experiments.
RT-PCR verification of differential genes
HO-8910PM cells at 50%-60% confluence were treat-
ed with different concentrations of PPI for 6, 12 and
24 h. Total RNA was extracted from cells. Reverse tran-
scription of RNA to cDNA was according to the kit
manual.
PCR amplification conditions were at 95℃ for 10 min,
95℃ 15 s, and 60℃ 1 min (40 cycles). Dissolution
curves were used to test if PCR amplified products
produced nonspecific bands using amplification con-
ditions of 95℃ 15 s, 60℃-95℃, increased by 1℃ ev-
ery min, 95℃ 15 s. Ct value was automatically ana-
lyzed by SDS software(ABI7500, Carlsbad, CA,
USA).
Statistical processing used SPSS 18.0 software. Data
from the two groups were compared by t-test, with P<
0.05 indicating statistical significance. Relative expres-
sion of genes was calculated using the 2-△△ Ct method.
Specific primer sequences (Table 1).
Verification of differentially expressed proteins
HO-8910PM cells in logarithmic phase were seeded in
a culture vessel. After 24 h, cells were treated by PPI at
a final concentration of 0.75 or 1.5 μg/mL. The con-
trol was only added the same volume medium. Pro-
teins of cells were extracted after treatment for 24 h.
Protein samples (50 μg) were separated on 10% sodi-
um dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) at 100 V for 90 min. Proteins were
wet-transferred at 4℃ for 100 V, 90 min to PVDF
membranes. Membrane were treated with 5% BSA for
3 h and incubated overnight at 4℃ with antibodies:β-actin 1∶2000, caspase 9 1∶300, cleaved Caspase 9 1∶
300, PIK3C2B 1∶500, c-Jun 1∶500, or Wnt5a 1∶
1000. After washing with Tris-HCL Buffer Solution
Tween (TBST), membranes were treated with second-
ary antibody (goat anti-mouse IgG 1∶2000 or goat an-
ti-rabbit IgG 1∶5000) for 2 h at room temperature be-
fore washing with TBST. ECL was used for color devel-
opment and a gel imager (Bio-Rad, Universal Hood II,
Hercules, CA, USA) was used for imaging. Procedures
of SDS-PAGE electrophoresis were repeated three
times.
RESULTS
Inhibitory effects of PPI on HO-8910PM cell
metastasis
The inhibitory effects of different concentrations of
PPI on HO-8910PM cell in vitro metastasis varied.
With PPI concentration increased, the metastatic ca-
pacity of the cells decreased. Differences were signifi-
cant between the experimental and control groups (P<
0.01) and between the two concentration groups (P<
0.01) (Table 2 and Figure1).
Screening of differentially expressed genes
Illumina chip results found 123 genes that tended to
vary in the two repeated experiments (Diffscore <-13
or >13). Of these, 70 genes were downregulated and
53 genes were upregulated. Among the 123 differential-
ly expressed genes, 71 that showed significant differenc-
es (Diffscore <-30 or >30, P=0.001) were linked to cell
apoptosis, proliferation, metastasis, invasion, or angio-
genesis (Table 3).
Differential genes and proteins expression
According to the results of the chip screening, we con-
ducted RT-PCR on several selected genes related to cell
apoptosis and metastasis with significant differences in
treated and untreated cells. PIK3C2B, Caspase 9 and
Wnt5A genes were downregulated with increasing PPI,
showing an evident dose-effect relationship. Expression
also showed a downward trend with extended PPI ex-
posure, suggesting decreased PPI effects with time. The
c-Jun gene was an exception. As the PPI dosage in-
Gene name
β-actin F
β-actin R
c-jun F
c-jun R
WNT5A F
WNT5A R
PIK3C2B F
PIK3C2B R
Caspase 9 F
Caspase 9 R
Primer sequences
5,-TGGCACCCAGCACAATGAA-3,
5,-CTAAGTCATAGTCCGCCTAGAAGCA-3,
5,-CACGTGAAGTGACGGACTGTTCTA-3,
5,-CAGGGTCATGCTCTGTTTCAGG-3,
5,-TTCGCCCAGGTTGTAATTGAAG-3,
5,-CTGCATGTGGTCCTGATACAAGTG-3,
5,-TGCTGCCAAGCCTACAACCTC-3,
5,-TTCAGGGATCCCACAGGACAA-3,
5,-GCCATATCTAGTTTGCCCACACC-3,
5,-CACTGCTCAAAGATGTCGTCCA-3,
Table1 mRNA specific primer sequences
Polyphyllin I (μg/mL)
0
0.75
1.5
Number of cells migrated
60±17
38±7a
13±8ab
Table 2 Effect of Polyphyllin I on migration capacity of
HO-8910PM cells after 48 h ( xˉ ±s)
Notes: Compared with control group, aP<0.01; compared with
0.75 μg/mL group, bP<0.01.
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creased and the exposure time was extended, c-Jun rela-
tive expression showed an upward trend. There were
significant differences between the experiment and con-
trol (P<0.05) (Figure 2).
To further validate the mechanism by which PPI exerts
its effects, we analyzed the in vitro expression of the
crucial proteins. Western blot analyses showed that the
expression of Caspase 9, Wnt5A and PIK3C2B was
downregulated with increasing PPI concentration after
24 h, and activated Caspase 9 increased in expression
as the effect of the PPI concentration strengthened.
Otherwise,the expression of c -Jun and p-c-Jun were
enhanced along with the increase of PPI concentration
(Figure 3).
0 μg/mL
0.75 μg/mL
1.5 μg/mL
Re
lat
ive
qu
an
tity
25
20
15
10
5
0
6 h 12 h 24 h
PIK3C2B
0 μg/mL
0.75 μg/mL
1.5 μg/mL
2.0
1.5
1.0
0.5
0
Caspase 9
6 h 12 h 24 h
0 μg/mL
0.75 μg/mL
1.5 μg/mL
Re
lat
ive
qu
an
tity
6
4
2
0 6 h 12 h 24 h
Wnt5a
Time of treatment
0 μg/mL
0.75 μg/mL
1.5 μg/mL
14
12
10
8
6
4
2
0
6 h 12 h 24 h
Time of treatment
c-Jun
Figure 2 RT-PCR analyses for HO-8910PM cells treated with different concentrations of PPI for 6, 12, 24 h respectively
PPI: polyphyllin I. PIK3C2B, CASPAS9 andWNT genes were downregulated with increasing PPI, showing an evident dose-effect re-
lationship. Expression also showed a downward trend with extended PPI exposure. The c-Jun gene was an exception. As the PPI
dosage increased and the exposure time was extended, c-Jun relative expression showed an upward trend.
A B C
Figure 1 Transwell chamber membrane invasion.
HO-8910PM cells were treated with different concentrations of PPI (crystal violet ×200). A: many cells were throught basement
membrane in control; B: with increasing PP I concentration (0.75μg/mL), the metastatic capacity of the cells decreased; C: few
cells could penetrate the basement membrane in 1.5μg/mL group. PPI: polyphyllin I. Differences were significant between the ex-
perimental and control groups and between the two concentration groups (n=3, P<0.01).
β-actin
Caspase 9
Cleaved caspase 9
Control 0.75 μg/mL 1.5 μg/mL
β-actin
C-Jun
Wnt5a
PIK3C2B
Control 0.75 μg/mL 1.5 μg/mL
Figure 3Western blot analyses on expression of caspase 9,Wnt and PIK3C2B
PPI: polyphyllin I. The expression of caspase 9, Wnt and PIK3C2B was downregulated with increasing PPI concentration after 24 h,
and activated caspase 9 increased in expression as the effect of the PPI concentration strengthened. C-Jun protein increased in
expression with increasing PPI dosage.
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Gene serial number
NM_032873.3
NM_003545.3
NR_003137.2
NM_005438.2
NM_001554.3
NM_001986.2
NM_003544.2
NM_152594.1
NM_003714.2
NM_002228.3
NM_001123375.1
NM_016639.1
NM_006216.2
NM_001001390.1
NM_014344.2
NM_005630.1
NM_000358.1
NM_003537.3
NM_014330.2
NM_032717.3
NM_000676.2
NM_003522.3
NM_014452.3
NM_013401.2
NM_018841.3
NM_020799.2
NM_178836.2
NM_004635.3
NM_003129.3
NM_021238.2
NM_003246.2
NM_005168.3
XM_943094.1
NM_022837.1
NM_001034077.4
NM_001009913.1
NM_001792.2
NM_015508.2
NM_003543.3
NM_021238.1
NM_002467.3
NM_006644.2
NM_003877.3
NM_017816.1
NM_016391.2
NM_015169.3
NM_007129.2
NM_002130.4
Gene
STS-1
HIST1H4E
RNU4-2
FOSL1
CYR61
ETV4
HIST1H4B
SPRED1
STC2
JUN
HIST2H3D
TNFRSF12A
SERPINE2
CD44
FJX1
SLCO2A1
TGFBI
HIST1H3B
PPP1R15A
AGPAT9
ADORA2B
HIST1H2BF
TNFRSF21
RAB3IL1
GNG12
STAMBPL1
PLD6
MAPKAPK3
SQLE
FAM60A
THBS1
RND3
ITPRIPL2
OBFC2A
HIST2H4B
DKFZp686O24166
CDH2
TIPARP
HIST1H4H
LOC650369
MYC
HSPH1
SOCS2
LYAR
HSPC111
RRS1
ZIC2
HMGCS1
Average signal value
Experimental group
346.082
315.966
918.487
629.178
653.216
349.732
495.788
548.408
496.714
562.472
221.956
4314.437
2308.289
2680.078
1310.506
857.8954
1746.634
342.2133
1505.284
365.5088
1102.903
293.1807
1077.072
948.0682
274.1029
1432.809
408.4599
2628.471
1417.03
725.2597
605.4728
654.7612
647.4328
742.9691
427.4166
447.1062
556.0802
1498.33
392.9638
4416.981
2821.029
3011.918
152.8327
944.7355
1249.35
938.5303
705.8544
3284.5
Control group
27.3191
34.9362
43.7870
59.6274
178.031
19.0187
44.1843
100.154
58.8478
148.328
17.9470
1189.004
276.8189
591.4918
382.485
301.4101
616.4378
86.97406
565.1768
109.5315
415.5197
60.22815
333.2905
271.6843
64.52874
604.1454
132.5535
1237.417
604.1332
318.0528
182.2941
313.1569
291.4312
409.6791
193.3938
217.4967
251.696
743.6614
147.8349
2132.464
1410.685
1653.067
41.60553
476.4539
663.2174
458.1306
372.2076
1603.089
103.294
103.0572
102.1883
100.4141
87.17748
85.69163
85.52663
82.49949
81.811
76.33192
72.27178
72.19204
70.81174
67.18413
62.18239
59.59216
59.51095
58.82693
58.66073
55.59966
45.3974
44.52826
44.09502
37.08645
36.95568
32.7325
30.47181
30.23944
29.99452
29.74821
29.35018
27.51756
27.26301
26.68575
26.31665
24.54539
24.49465
23.408
23.35906
22.89385
22.37365
21.42639
21.01739
20.2809
19.93919
19.79935
19.31639
18.87299
Diffscore
Experimental group/Control group
Table 3 Differential gene expression in HO-8910PM cells treated with PPI among experimental and control groups
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Gene serial number
NM_001901.2
NM_032993.1
NM_001251.2
NM_003541.2
NM_006745.3
NM_017656.1
NM_003659.1
NM_003392.3
NM_005949.1
NM_000314.3
XR_036921.1
NM_012293.1
NM_002775.3
XR_038054.1
NM_025202.
NM_001229.2
NM_001001977.1
NM_012477.2
NM_005980.2
XM_001130700.1
NM_022746.2
NM_016126.1
NM_138439.1
NM_145249.2
NM_031910.3
NM_012228.2
NM_022126.2
NM_032488.2
NM_003260.3
NM_014214.1
NM_000240.2
NM_005258.2
NM_002038.2
NM_002646.2
NM_003739.4
NM_002292.2
NM_138413.2
NM_003064.2
NM_004070.2
NM_002800.4
NM_024760.1
NM_024087.1
XM_936226.1
NM_001976.2
NM_152773.2
NM_014353.4
NM_199280.2
NM_002609.3
Gene
CTGF
NOLA1
CD68
HIST1H4K
SC4MOL
ZNF562
AGPS
WNT5A
MT1F
PTEN
LOC399965
PXDN
HTRA1
LOC642567
EFHD1
CASP9
ATP5E
LOC729843
S100P
LOC729580
MOSC1
C1orf41
FLYWCH2
IFI27L1
C1QTNF6
MSRB2
LHPP
CNFN
TLE2
IMPA2
MAOA
GCHFR
IFI6
PIK3C2B
AKR1C3
LAMB2
C10orf65
SLPI
CLCNKA
PSMB9
TLE6
ASB9
LOC653879
ENO3
TCTEX1D2
RAB26
FAM179A
PDGFRB
Average signal value
Experimental group
344.8142
529.7524
653.6155
297.4224
651.663
315.2137
644.2902
143.5181
237.1883
364.8773
1650.847
990.3159
582.2866
242.745
687.8907
122.1136
4110.001
417.5804
3479.985
90.13102
1194.445
1108.259
705.6525
881.497
545.8157
1032.75
387.9189
251.624
78.4521
1173.414
152.7963
1088.508
546.237
168.9783
3718.225
77.9724
88.32175
830.6847
32.80941
81.09667
148.4603
441.01
56.30883
173.2242
173.5097
54.71972
20.57673
81.36383
Control group
139.3082
293.6198
289.8108
152.5668
286.7173
171.2174
365.2459
271.7138
456.3574
770.6759
2984.948
1881.928
1074.875
478.2736
1255.236
322.8308
7268.293
825.8675
8371.298
259.6275
2555.335
2140.025
1374.438
2029.325
1262.178
2201.984
884.5873
619.1241
233.9357
2619.835
403.1239
2599.676
1184.531
491.8258
8234.99
299.5666
298.9954
2107.319
161.1909
296.4986
398.9192
1106.669
223.5942
572.5278
518.5749
245.2926
197.8507
318.6978
Experimental group/Control group
17.3335
16.51604
16.13743
15.38945
15.02108
14.9302
13.47172
-14.67792
-14.90383
-15.74173
-17.31014
-17.31014
-17.99499
-18.90868
-20.44697
-20.68736
-22.65136
-22.90019
-23.07171
-23.26918
-23.52271
-26.19225
-28.03999
-29.68712
-31.11746
-31.22862
-31.23408
-31.76269
-32.03365
-33.87939
-34.51831
-34.7992
-35.36266
-35.68323
-35.76765
-36.85546
-36.9533
-37.66486
-38.73921
-41.37426
-43.73455
-44.90459
-45.10002
-46.22949
-48.89422
-49.07536
-53.75527
-55.76235
Diffscore
Table 3 Differential gene expression in HO-8910PM cells treated with PPI among experimental and control groups
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DISCUSSION
Previous research from our group found that PPI killed
and inhibited the growth of ovarian cancer cells in vi-
tro.6 Ovarian serous cystadenocarcinoma is the malig-
nant neoplasm with the highest incidence and suscepti-
bility to abdominopelvic cavity metastasis and lymph
node metastasis of all ovarian cancers. In this study, we
simulated the in vivo environment to observe the effect
of PPI on the invasive ability of HO-8910PM cells in
an invasive basement membrane experiment (transwell
chamber assay). The results showed that the invasive
ability of the cells decreased with 0.75 or 1.5 μg/mL of
PPI for 48 h, with significant differences between treat-
ment and control groups. Thus, PPI had an inhibitory,
apoptosis and antimetastasis effect on HO-8910PM
cells in vitro.
The mechanisms of TCM on tumor growth and metas-
tasis mainly include inducing tumor cell apoptosis, reg-
ulating matrix metalloproteinase secretion, reversing
multidrug resistance, and enhancing antitumor immu-
nity.8-10 In order to study the mechanism of PPI, accord-
ing to the results of in vitro inhibition of proliferation
and metastasis on HO-8910PM, the study firstly
screen by Illmina gene expression profile. The results
show that there are 123 different genes, with 70 genes
downregulated and 53 genes upregulated. The genes
were involved in multiple signal transduction path-
ways, including apoptosis, proliferation and metastasis.
We propose that the anti-ovarian cancer effect of PPI
might be associated with genetic changes in these path-
ways.
Chip screening showed that the c-Jun gene of experi-
ments was upregulated compared to the control group.
This is a specific substrate of c-Jun N-terminal kinase,
Gene serial number
NM_002168.2
NM_181712.2
NM_153225.2
NM_181712.4
XR_018394.2
NM_025149.4
NM_000943.4
NM_032290.2
NM_001030011.1
NM_001012716.1
NR_002196.1
NM_004585.2
NM_002961.2
NM_003881.2
XR_018049.2
NM_004233.3
NM_000638.2
NM_001632.2
NM_002023.3
NR_002770.1
NM_000898.3
NM_000691.3
NM_198474.2
NM_030792.4
NM_002191.2
NM_001038.4
NM_152737.2
NM_014631.2
NM_138288.2
NM_003280.1
NM_001613.1
NM_001307.3
NM_005218.3
Gene
IDH2
ANKRD38
RPESP
KANK4
LOC440063
ACSF2
PPIC
ANKRD32
OPN3
C18orf56
H19
RARRES3
S100A4
WISP2
LOC392871
CD83
VTN
ALPP
FMOD
DIO3OS
MAOB
ALDH3A1
OLFML1
GDPD5
INHA
SCNN1A
RNF182
SH3PXD2A
C14orf147
TNNC1
ACTA2
CLDN7
DEFB1
Average signal value
Experimental group
292.1541
632.326
52.06253
439.869
3218.146
69.04391
533.7675
77.93024
210.0855
104.1488
1343.078
31.27712
410.4211
627.0193
213.9286
332.5733
74.53746
2615.495
71.23046
40.09093
48.25962
329.7927
353.3866
100.9981
53.51229
1302.976
244.0747
114.6727
104.3805
73.8914
269.2807
135.0727
201.5031
Control group
733.1027
1948.322
307.5731
1600.467
7844.85
318.0425
1462.913
510.7194
883.7712
523.3942
5261.292
297.2088
1627.042
3518.056
742.0889
1239.519
429.1161
8253.644
363.5186
317.3402
326.9847
1664.795
1323.335
470.4892
424.8257
4822.262
866.4651
575.4124
699.7713
772.5579
1369.728
999.0081
2552.266
Experimental group/Control group
-58.08978
-58.49552
-59.44795
-59.68919
-62.12342
-62.18739
-67.96772
-69.1872
-69.7235
-70.12389
-70.12389
-71.60889
-75.11002
-76.33192
-76.86445
-79.09878
-79.19178
-82.58296
-84.7128
-85.52663
-88.44852
-90.27982
-91.4192
-95.38821
-97.21037
-97.62897
-100.7541
-103.2969
-104.103
-116.7747
-332.3645
-332.3645
-332.3645
Diffscore
Table 3 Differential gene expression in HO-8910PM cells treated with PPI among experimental and control groups
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which is activated in cell apoptosis after specific bind-
ing. JNK/c-Jun signaling pathway plays a critical role
in regulating a wide range of cellular activities from cell
proliferation and differentiation to programmed cell
death, and also in the diseases development, such as
cancer. Transcriptional factor c-Jun, one major mem-
ber of AP-1 family, is an important downstream effec-
tor of JNK activation. The increased phosphorylated
protein p-c-Jun indicating JNK/c-Jun signaling path-
ways are activated. The activation of the pathway leads
to the release of cytochrome C in mitochondria. Even-
tually it occur apoptosis. Caspases are a group of pro-
teinases with high homology that have a key role in
apoptosis. They are the important initiator in mito-
chondrial apoptosis pathway. Shi et al 11 studied saxifra-
gifolin D (SD) effects on growth inhibition and apop-
tosis induction of human liver cancer HepG2/ADM
cells. They found that after HepG2/ADM cells were
treated with SD, the protein level of procaspase 9 and
procaspase 3 increased and activated Caspase 9 and
Caspase 3 increased compared with the control. Dai et
al 12 reported that platycodin D from Jiegeng (Radix
Platycodi) had an inhibitory effect on the in vitro
growth of the human lung adenocarcinoma cell line
A549 and accelerated apoptosis via mitochondrial path-
way. The expression of activated Caspase 9 protein af-
ter 24 h increased with platycodin D concentration.
Xiao et al 13 found several apoptosis-related proteins
such as Caspase 9 and Caspase 3, were activated after
treatment with PPI for 24 h, and thereby accelerated
SKOV3 cell apoptosis. Through gene chip screening,
the experiments found that Caspase 9 showed de-
creased levels. RT-PCR indicated that Caspase 9 was
downregulated with time and PPI dose, with evident
dependence on time and dose. Protein levels in our
study indicated that Caspase 9 expression decreased
with PPI dose, and activated Caspase 9 (cleaved Cas-
pase 9) increased with PPI dose. This showed that PPI
activated Caspase 9, thus causeing apoptosis.
Furthermore, Liu et al 14 found that in colorectal can-
cer tissue VEGF-C expression was related to c-Jun ex-
pression in moderately and highly differentiated adeno-
carcinomas. With cancer progression, c-Jun protein ex-
pression gradually decreased while VEGF-C expression
gradually increased, suggesting that c-Jun protein
might be an inhibiting factor for VEGF-C expression.
Li et al 15 found that activated JNK induced cell au-
tophagy through upregulation of beclin1 expression.
RT-PCR and protein studies in our study showed that
c-Jun gene and protein levels were upregulated with in-
creasing PPI dosage. We hypothesize that PPI might ac-
tivate c-Jun expression and the JNK signaling pathway,
then induce apoptosis of HO-8910PM cells, mean-
while restrain angiogenesis gene expression including
VEGF, and therefore inhibit tumor cell metastasis.
PIK3C2B is a member of the PI3K family, which is im-
portant in proliferation, tumor conversion, cell surviv-
al, migration and cellular protein transport.16 Scrima et
al 17 found that high expression of PI3K promoted the
incidence and development of non-small cell lung can-
cer. By silencing subtype P110α of PI3K in
NCI-H460 cells, they discovered that PI3K inhibited
the expression of P110α and significantly inhibited
NCI-H460 cell growth. Du et al 18 showed that
HIF-1α binds to tumor inhibitor protein under nor-
mal oxygen concentrations. However, anaerobic condi-
tions inhibit the hydroxylation of HIF-1α and acceler-
ate its intranuclear transfer to generate an active com-
pound by binding to HIF-1β. In this way, HIF-1α ac-
celerates the transcription of VEGF and other angio-
genesis factors and increases tumor angiogenesis. Gene
and protein analysis in this paper indicated that
PIK3C2B expression in decreased in ovarian cancer
cells after PPI treatment with increasing PPI concentra-
tion. We propose that PPI might inhibit the expression
of genes that promote angiogenesis and decrease tumor
angiogenesis by downregulating the PIK3C2B gene,
which results in the inhibition of HO-8910PM cell
metastasis.
The Wnt family is important in cell proliferation, dif-
ferentiation and tumor formation. Wnt5A is a major
member of the Wnt family. Capable of activating the
Wnt5a/β-catenin pathway and the Wnt/Ca2 + pathway,
Wnt5A affects cell migration, invasion, and angiogene-
sis in tissues and is important for tissue recovery and
homeostasis. Thus Wnt5A expression may be upregu-
lated, downregulated or deleted in many tumors aris-
ing from the epithelium and mesoderm. The upregula-
tion of Wnt5A has been found in melanoma, lung,
breast, ovarian, gastric and prostate carcinoma.19-21
Compared with corresponding normal tissues, Wnt5A
expression in endometrial carcinoma and high-risk neu-
roblastoma is downregulated.22 Therefore, overexpres-
sion of Wnt5A has a distinctive cancer-inhibiting or
cancer-inducing effect, according to cell type. In this
study, compared with the control group, Wnt5A ex-
pression in the experimental group was decreased, pos-
sibly because of Wnt5A antagonism by PPI, which in-
hibits the proliferation and metastasis of HO-8910PM
cells.
In conclusion, this study demonstrated that PPI as a
TCM had a powerful antitumor and anti transfer activ-
ity. It could activate c-Jun expression and the JNK sig-
naling pathway, elicit cell apoptosis via the mitochon-
drial-mediated caspase activation pathway and finally
inhibit tumor growth and migration in vitro. Selective
intervention of apoptotic signals, induction of pro-
grammed cell apoptosis and inhibition of cancer cell
metastasis are effective means for treating malignant tu-
mors. So PPI might be used as a novel treatment for
ovarian cancer due to its multipathway effect on the
ovary serous adenocarcinoma cell line HO-8910PM.
REFERENCES
1 Ding L. Clinical observation of cisplatin intraperitoneal
332
JTCM |www. journaltcm. com June 15, 2013 |Volume 33 | Issue 3 |
Gu LH et al. / Experimental Study
chemotherapy combined with AiDi injection in advanced
and recurrent ovarian cancer. Zhong Hua Shi Yong Yi Yao
Za Zhi 2009; 9(2): 116-118.
2 Zhang J. Treatment progression in TCM of ovarian can-
cer. Ya Tai Chuan Tong Yi Yao 2008; 4(9): 127-129.
3 Zhao BS, Zhu YD, Ma Y, et al. Research progress in Tradi-
tional Chinese Medicine polyphylla. Zhong Guo Shi Yan
Fang Ji Xue Za Zhi 2011; 17(11): 267.
4 Wu S, Wu W, Zheng YL. Simultaneous determ ination of
four steroidal saponins compounds in paris ployphylla by
high performance liquid chromatography reversed- phase.
Shi Zhen Guo Yi Guo Yao 2007; 18(8): 1896-1897.
5 Sun J, Liu BR, Hu WJ, et al. In vitro anticancer activity of
aqueous extraets and ethanol extracts of fifteen Traditional
Chinese Medicines on human digestive tumor cell lines.
Phytother Res 2007; 21: 1102.
6 Gu LH, Feng JG, Qian LJ, Ma SL. Research on prolifera-
tion inhibitory effect of Paris saponin I on high metastatic
human ovarian cancer cell line HO-8910PM in vitro.
Zhong Hua Zhong Yi Yao Xue Kan 2012; 3(10): 2212-
2215.
7 Xu SH, Qian LJ, Mou HZ, et al. Establishment of a high-
ly metastatic human ovarian cancer cell line
(HO-8910PM) and its characterization. J Exp Clin Can-
cer Res 1999; 18: 233-239.
8 Zhu LL, Li HH. An experimental study of proliferation
inhibition and apoptosis inducement of rhizoma paridis
on SGC-7901 cells. Shi Zhen Guo Yi Guo Yao 2009; 20
(6): 1501-1502.
9 Liu GX, Wang TT, Hu WJ. Anti-tumor effect of ethano-
lic extracts of Paris polyphylla on primary cancer cells in
malignant pleural effusion or ascites. Shi Yong Lao Nian
Yi Xue 2008; 22(2): 101-104.
10 Yan LL, Zhang YJ, Gao WY, et al. In vitro and in vivo an-
ticancer activity of steroid saponins of paris polyphylla var.
yunnanensis. Exp Oncol 2009; 31(1): 27-32.
11 Shi JM, Zhang DM, Yao N, et al. Studies of the cell prolif-
erative inhibition and apoptosis induced by Saxifragifolin
D on HepG2/ADM cells. Zhong Guo Yao Li Xue Tong
Bao 2012; 28(1): 34-38.
12 Dan Q, Chen Z, Ge YQ, et al. Mechanism of platyco-
din D-induced humane long cancer cells A549 apopto-
sis. Zhong Guo Zhong Yao Za Zhi 2012; 37(17):
2626-2629.
13 Xiao X, Bai P, Bui Nguyen TM, et al. The antitumoral ef-
fect of Paris Saponin I associated with the induction of
apoptosis through the mitochondrial pathway. Mol Can-
cer Ther May 2009; 8: 1179-1188.
14 Liu CL, Deng YH, Wang CY, Gao M, Liu Y. The expres-
sion of C-jun and VEGF-C in colorectal cancer tissues
and its clinical significance. Chin Arch Gen Surg (Elec-
tronic Edition) 2010; 4(5): 440-444.
15 Li DD, Wang LL, Deng R, et al. The pivotal role of c-jun
NH2-terminal kinase-mediated Beclin1 expression during
anticancer agents-indeced autophagy in cancer cells. Onco-
genen 2009; 28: 886-898.
16 Cai X, Srivastava S, Sun Y, et al. Tripartite motif contain-
ing protein 27 negatively regulates CD4 T cells by ubiqui-
tinating and inhibiting the class II PI3K-C2β. Proc Natl
Acad Sci 2011; 108(50): 20072-20077.
17 Scrima M, De Marco C, Fabiani F, et al. signaling
networks associated with AKT activation in non-small
cell lung cancer (NSCLC): new insights on the role of
phosphatydil-inositol-3 kinase. PLoS One 2012; 7(2):
e30427.
18 Du J, Xu R, Hu Z, et al. PI3K and ERK-Induced Rac1 ac-
tivation mediates hypoxia-induced HIF-1a expression in
MCF-7 breast cancer cells. PLoS One 2011; 6(9): e25213.
19 Laezza C, D'Alessandro A, Paladino S, et al. Anandamide
inhibits the Wnt/β-catenin signalling pathway in human
breast cancer MDA MB 231 cell. Eur J of Cancer 2012; 48
(16): 3112-3122.
20 Zhang XL, Zheng JH. The relationship between WNT5A
and tumor. Guo Ji Zhong Liu Xue Za Zhi 2011; 38(2):
83-86.
21 Hansen C, Howlin J, Tengholm A, et al. WNT-5a-in-
duced phosphorylation of DARPP-32 inhibits breast can-
cer cell migration in a CREB-dependent manner. J Biol
Chem 2009; 284(40): 27533-27543.
22 Blanc E, Goldschneider D, Douc-Rasy S, Bénard J, Ra-
guénez G. Wnt-5a gene expression in malignant human
neuroblasts. Cancer Lett 2005; 228(1-2): 117-123.
333
